Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 Nov;56(11):5852-7.
doi: 10.1128/AAC.01323-12. Epub 2012 Sep 4.

Comparison of fluconazole renal penetration levels in healthy and Candida albicans-infected Wistar rats

Affiliations
Comparative Study

Comparison of fluconazole renal penetration levels in healthy and Candida albicans-infected Wistar rats

Francine Johansson Azeredo et al. Antimicrob Agents Chemother. 2012 Nov.

Abstract

The aims of this study were to evaluate free levels of fluconazole (FCZ) in the kidneys of healthy and Candida albicans-infected Wistar rats using microdialysis and to establish the relationship between free renal and total plasma levels under both conditions. Microdialysis recovery rates were determined in vitro by dialysis, and retrodialysis recovery rates were determined in vivo by retrodialysis. The recovery rate was around 50%, independent of the method, drug concentration, or condition (in vitro or in vivo) used. FCZ kidney penetration in healthy and infected rats was investigated after the administration of 10 mg/kg of body weight intravenously (i.v.) or 50 mg/kg orally (n = 6/group) and blood and microdialysate sample harvesting at predetermined time points up to 24 and 18 h, respectively. There were no statistical differences between the area under the free concentration-time curve (AUC(0-∞)) values in plasma and in tissue for either healthy or infected groups for the same dose regimen investigated. The antifungal tissue penetrations were similar for both doses and under all conditions investigated (ranging from 0.77 to 0.84). The unbound fraction of FCZ was concentration independent (86.0% ± 2.0%), allowing the prediction of free renal levels using pharmacokinetic parameters obtained from total plasma fitting. The results showed that free renal and free plasma levels are similar in healthy and systemically C. albicans-infected rats. Therefore, free plasma levels are a good surrogate to estimate free FCZ renal concentrations in systemic candidiasis and can be used to optimize dosing regimens for this drug.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Mean FCZ total plasma (■) and free kidney (●) concentration-time profiles in healthy (A and C) and Candida albicans-infected (B and D) Wistar rats after 50-mg/kg oral (A and B) or 10-mg/kg i.v. bolus (C and D) dosing. Solid lines represent total plasma levels fitted by using equations 3 and 4 after i.v. or oral dosing, respectively. Dashed lines represent free kidney levels predicted by using equations 5 and 6 for i.v. and oral dosing, respectively (see the text for details) (means ± standard deviations are shown; n = 6/group).

Similar articles

Cited by

References

    1. Andes D. 2006. Pharmacokinetics and pharmacodynamics of antifungals. Infect. Dis. Clin. North Am. 20:679–697 - PubMed
    1. Andes D. 2003. In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrob. Agents Chemother. 47:1179–1186 - PMC - PubMed
    1. Araujo BV, Silva CF, Haas SE, Dalla Costa T. 2008. Microdialysis as a tool to determine the free kidney levels of voriconazole in rodents: a model to study the technique feasibility for a moderately lipophilic drug. J. Pharm. Biomed. Anal. 47:876–881 - PubMed
    1. Araujo BV, Silva CF, Haas SE, Dalla Costa T. 2009. Free renal levels of voriconazole determined by microdialysis in healthy and Candida sp.-infected Wistar rats. Int. J. Antimicrob. Agents 33:154–159 - PubMed
    1. Balk MW, Crumrine MH, Fischer GW. 1978. Evaluation of miconazole therapy in experimental disseminated candidiasis in laboratory rats. Antimicrob. Agents Chemother. 13:321–325 - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts